关于 Edoxaban API
治疗类别 Cardiology（心血管）
CAS 编号
480449-70-5
API 技术
合成
剂型
片剂
Dr Reddy's 开发状态
可用的
可用的法规申报文件
日本 DMF
Mechanism of Action
Edoxaban is a direct oral anticoagulant (DOAC) that acts as a factor Xa inhibitor. It works by blocking the activity of factor Xa, a key component of the coagulation cascade.
Factor Xa plays a central role in the blood coagulation process, converting prothrombin to thrombin and leading to the formation of a blood clot. By inhibiting the activity of factor Xa, edoxaban helps to reduce the formation of blood clots and the risk of thromboembolic events such as stroke and deep vein thrombosis (DVT).
Edoxaban works differently from traditional anticoagulants such as warfarin, which work by blocking the recycling of vitamin K and the synthesis of coagulation factors. Unlike warfarin, edoxaban does not require frequent monitoring or dose adjustments and has a more predictable anticoagulant effect.
Overall, the mechanism of action of edoxaban involves the inhibition of factor Xa, leading to a reduction in the formation of blood clots and the risk of thromboembolic events.
Indication
Edoxaban is FDA-approved for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AF). It is also indicated for the treatment and reduction of risk of recurrence of deep vein thrombosis (DVT) and pulmonary embolism (PE).
Atrial Fibrillation: Edoxaban is indicated for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation who have one or more risk factors, such as age, congestive heart failure, hypertension, or previous stroke or transient ischemic attack (TIA).
Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE): Edoxaban is indicated for the treatment of DVT and PE, and for the reduction of the risk of recurrent DVT and PE following initial treatment with a parenteral anticoagulant.
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!
Related APIs
Clopidogrel Bisulfate (For 1)（硫酸氢氯吡格雷，1 晶型）
Cardiology（心血管）
Dabigatran Etexilate Mesylate（甲磺酸达比加群酯）
Cardiology（心血管）
Doxazosin Mesylate（甲磺酸多沙唑嗪）
Cardiology（心血管）
Ezetimibe（依折麦布）
Cardiology（心血管）
Fondaparinux Sodium（磺达肝癸钠）
Cardiology（心血管）
Lacidipine（拉西地平）
Cardiology（心血管）
Bempedoic Acid（贝派地酸）
Cardiology（心血管）
Ramipril（雷米普利）
Cardiology（心血管）
Rivaroxaban（利伐沙班）
Cardiology（心血管）
Treprostinil（曲前列尼尔）
Cardiology（心血管）
Valsartan（缬沙坦）
Cardiology（心血管）
Tafamidis Free Acid（氯苯唑酸游离酸）
Cardiology（心血管）
Clopidogrel Bisulfate (Form 2)（硫酸氢氯吡格雷，2 晶型）
Cardiology（心血管）
Metoprolol Succinate（琥珀酸美托洛尔）
Cardiology（心血管）
Amlodipine Besylate（苯磺酸氨氯地平）
Cardiology（心血管）
Apixaban（阿哌沙班）
Cardiology（心血管）
Losartan Potassium（氯沙坦钾）
Cardiology（心血管）
Ticagrelor（替格瑞洛）
Cardiology（心血管）
Atorvastatin Calcium (Form 1)（阿托伐他汀钙，1 晶型）
Cardiology（心血管）
Acoramidis（阿可拉米地）
Cardiology（心血管）
Enalapril Maleate（马来酸依那普利）
Cardiology（心血管）
Edoxoban （甲苯磺酸依度沙班一水合物）
Cardiology（心血管）
Sacubitril ‑ Valsartan（沙库巴曲缬沙坦）
Cardiology（心血管）
Atorvastatin Calcium (Amorphous & Form P)（阿托伐他汀钙，无定形 & P晶 型）
Cardiology（心血管）
免责声明
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.